Durgam Suresh K.

CIK 00018299581 companyBEDMINSTER, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001829958

Recent Transactions

50 trades

Award
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02+13,134→ 13,134 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−53,967→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−33,443→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−17,916→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02−8,742→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Common Stock
2025-04-02$132.00/sh−42,913→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−13,133→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02−13,134→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−24,621→ 0 total
Award
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02+8,742→ 8,742 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−18,714→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−17,485→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-10−7,345→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-10+7,345→ 46,029 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-10$131.24/sh−3,116→ 42,913 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-06$131.19/sh−5,572→ 38,684 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-06−13,133→ 13,133 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-06+13,133→ 44,256 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-01+8,742→ 34,832 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-01−8,742→ 17,485 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-01$128.20/sh−3,709→ 31,123 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-02-03+24,621→ 24,621 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2025-01-31+11,017→ 30,820 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-01-31$127.00/sh−4,730→ 26,090 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$66.96/sh−661→ 19,803 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$65.06/sh−2,179→ 21,336 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$65.89/sh−872→ 20,464 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-10−7,345→ 7,345 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-10+7,345→ 23,515 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-07$66.34/sh−3,728→ 18,892 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-07$66.86/sh−2,722→ 16,170 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-06+13,132→ 22,620 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-06−13,132→ 26,266 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-01+26,227→ 26,227 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$70.16/sh−1,400→ 10,800 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$71.02/sh−1,312→ 9,488 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$69.38/sh−1,400→ 12,200 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-23+7,907→ 13,600 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-02-23−7,907→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-02$67.49/sh−3,847→ 5,693 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-02$66.69/sh−2,320→ 9,540 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-01+11,860→ 11,860 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-01-02−62,282→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-01-02$70.41/sh−37,427→ 24,855 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-01-02$70.80/sh−22,645→ 2,210 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-01-02$19.87/sh+62,282→ 62,282 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-01-02$71.77/sh−2,210→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-12-13$65.00/sh−21,262→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-07-17$65.00/sh−1,842→ 21,262 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-03-13$45.08/sh−6,998→ 23,450 total

Companies

Intra-Cellular Therapies, Inc.
EVP, Chief Medical Officer

Recent Filings

Address

C/O INTRA-CELLULAR THERAPIES, INC. 135 ROUTE 202/206, SUITE 6

BEDMINSTER, NJ, 07921

View on SEC.gov